ZWEIFACH SANFORD S 4
Research Summary
AI-generated summary
Compugen (CGEN) Director Sanford Zweifach Receives RSU and Option Grants
What Happened
- Sanford S. Zweifach, a director of Compugen Ltd. (CGEN), received two compensation awards on July 29, 2026: 7,500 restricted stock units (RSUs) and a 10,000-share derivative award (option-style grant). Both awards were granted at $0 per share (no cash exchanged at grant).
Key Details
- Transaction date: 2026-07-29; filing date (Form 4): 2026-07-30 (timely).
- Awards and reported prices: 7,500 RSUs @ $0.00; 10,000 derivative/option-style award @ $0.00.
- Vesting (per filing footnotes): 25% vests on Oct 1, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued service (applies to both awards per F1/F2).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Transaction code: A = Grant/Award. These are compensation grants, not open-market purchases or sales.
Context
- RSUs are a promise to deliver shares upon vesting (no shares are typically issued until vesting); the derivative/option grant will become exercisable only as it vests. Neither award represents an immediate cash purchase or sale by the director.
- Such grants are common as part of director compensation and do not, by themselves, indicate the director bought or sold company stock.